Madeleine Farman
Madeleine Farman is a senior reporter for PEI Group’s Private Equity International and Secondaries Investor titles, based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.
The Maryland-headquartered multifamily office has its eye on small growth and buyout managers with specialist strategies across North America and Western Europe.
LPs consider a vast number of metrics, including transparency, exposure and co-investment opportunities, before determining whether a fundraise was successful.
Supply from managers looking to the secondaries market to hold onto assets for longer periods continues to grow.
There are subtleties when it comes to how investors treat funds closing wide of the mark.
Multiple managers have either closed or expect to close their latest private equity flagships below target – something unthinkable a few years ago.
Clayton, Dubilier & Rice Fund XII, which launched last year, has a hard-cap of $23bn.
Hunter Point’s investment closely follows its stake purchase in consumer giant L Catterton last month.
ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €2.4bn.
Tender offers plus staples can be a powerful tool to provide liquidity to cash-strapped LPs.
The life sciences unit increased its original €175m hard-cap to allow for more investment into the portfolio companies it seeks to back.